{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as dominantly inherited Parkinson's disease caused by mutations in LRRK2."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Mutant dardarin triggers cell loss over a period of a few days resulting in retraction of neuronal processes and nuclear shrinkage.",
          "judgment": "Yes",
          "reasoning": "The cell death assay used reflects the disease mechanism of neuronal degeneration in Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We used these constructs to examine the kinase activity of dardarin and show that our kinase-dead constructs had decreased activity.",
          "judgment": "Yes",
          "reasoning": "The study included wild-type and mutant controls and performed experiments in replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type and mutant dardarin were able to efficiently autophosphorylate.",
          "judgment": "No",
          "reasoning": "The study did not mention using known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G2019S variant in LRRK2 showed increased kinase activity and cell death, supporting its pathogenic role. However, due to the lack of variant controls, the evidence strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as dominantly inherited Parkinson's disease caused by mutations in LRRK2."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Mutant dardarin triggers cell loss over a period of a few days resulting in retraction of neuronal processes and nuclear shrinkage.",
          "judgment": "Yes",
          "reasoning": "The cell death assay used reflects the disease mechanism of neuronal degeneration in Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We used these constructs to examine the kinase activity of dardarin and show that our kinase-dead constructs had decreased activity.",
          "judgment": "Yes",
          "reasoning": "The study included wild-type and mutant controls and performed experiments in replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type and mutant dardarin were able to efficiently autophosphorylate.",
          "judgment": "No",
          "reasoning": "The study did not mention using known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The I2020T variant in LRRK2 showed increased kinase activity and cell death, supporting its pathogenic role. However, due to the lack of variant controls, the evidence strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as dominantly inherited Parkinson's disease caused by mutations in LRRK2."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Mutant dardarin triggers cell loss over a period of a few days resulting in retraction of neuronal processes and nuclear shrinkage.",
          "judgment": "Yes",
          "reasoning": "The cell death assay used reflects the disease mechanism of neuronal degeneration in Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We used these constructs to examine the kinase activity of dardarin and show that our kinase-dead constructs had decreased activity.",
          "judgment": "Yes",
          "reasoning": "The study included wild-type and mutant controls and performed experiments in replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type and mutant dardarin were able to efficiently autophosphorylate.",
          "judgment": "No",
          "reasoning": "The study did not mention using known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The R1441C variant in LRRK2 showed increased kinase activity and cell death, supporting its pathogenic role. However, due to the lack of variant controls, the evidence strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as dominantly inherited Parkinson's disease caused by mutations in LRRK2."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Mutant dardarin triggers cell loss over a period of a few days resulting in retraction of neuronal processes and nuclear shrinkage.",
          "judgment": "Yes",
          "reasoning": "The cell death assay used reflects the disease mechanism of neuronal degeneration in Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "We used these constructs to examine the kinase activity of dardarin and show that our kinase-dead constructs had decreased activity.",
          "judgment": "Yes",
          "reasoning": "The study included wild-type and mutant controls and performed experiments in replicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type and mutant dardarin were able to efficiently autophosphorylate.",
          "judgment": "No",
          "reasoning": "The study did not mention using known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The Y1699C variant in LRRK2 showed increased kinase activity and cell death, supporting its pathogenic role. However, due to the lack of variant controls, the evidence strength is PS3_supporting."
    }
  ]
}
